Business Wire

NAGA Announces Merger With Trading App Capex.com. Octavian Patrascu, the Founder of Capex, Is to Personally Inject USD 9 Million Into the Company via a Convertible Bond.

19.12.2023 12:29:00 CET | Business Wire | Press Release

Share

NAGA announces merger with trading app Capex.com. Octavian Patrascu, the Founder of Capex, is to personally inject USD 9 million into the company via a convertible bond, setting the stage for a strategic merger between Capex.com and NAGA.

The union will be facilitated through a non-cash capital increase and is expected to forge a powerful and profitable Fintech platform, combining the strengths of both Groups. With a collective user base of 1.5 million worldwide, the newly merged company is projected to generate over USD 250 million in revenue over the next three years.

  • Joint group will generate close to USD 90 million in 2023 with EBITDA of USD 6 million
  • Capex.com – a multi-asset brokerage will reverse into NAGA Group AG
  • Cash contribution of USD 15 million by Capex and its Founder as part of the business combination
  • Immediate cost synergies of more than USD 10 million annually

The NAGA GROUP (XETRA: N4G, ISIN: DE000A161NR7), provider of the All-in-One Financial Super App, NAGA, is pleased to announce that it has agreed terms to merge with the multi-asset trading FinTech platform Capex.com by way of a non-cash capital increase.

Capex.com is a global regulated, fast growing (80% CAGR over the past three years) FinTech platform with licenses in Europe and Abu Dhabi. Capex nurtures a user base of more than 60,000 users who have been active in 2023 alone and grows by more than 15,000 signups monthly on average. The company has raised USD 31 million in equity financing thus far, and its revenues have developed rapidly in the past three years from USD 26 million revenue in 2021 to an estimated USD 40 million in 2023, despite a very challenging market environment.

Capex operates with more than five licenses, including the prestigious ADGM license in Abu-Dhabi. The company is led by Founder and CEO Octavian Patrascu, a former Key shareholder who was leading the growth of CFD broker markets.com (2010-2015) and brings invaluable experience from his tenure that culminated in markets.com's USD 550 million sale to Playtech.

Strong synergy effects driving 40 % EBITDA in short term.

The joint entities will operate 8 licenses globally, and this year are estimated to generate USD 90 million in joint revenue with an EBITDA of USD 6.5 million. The joint annual trading volume in 2023 will stand around USD 300 billion dollars and the combined platforms will be home to 1.5 million users from more than 100 countries expecting to reach 5 million users by 2025. With its joint licenses, NAGA and Capex can operate in more than 50 countries, including the fast-growing MENA region where NAGA will be able to roll-out its innovative social trading at scale.

NAGA’s proprietary technology will leverage Capex existing client’s base with the offering of social trading, payment services as well as spot Crypto, thereby increasing lifetime value of the clients of the platform and therefore yielding additional profits. Overall, it is expected that the business combination will be able to save up to USD 10 million in annual operating expenses, such as regulatory overheads, headcount, technology and costs of goods sold (COGS). Joint marketing efforts will lead to higher bidding power on paid traffic and higher domain and platform authority expected to improve client acquisition cost significantly as well as its brand reputation.

Capex and its shareholders to invest a total of USD 15 million in equity into business combination.

The transaction secures extension of the repayment of NAGA’s current USD 5 million loan to the end of 2025, further improves liquidity for the immediate term for growth and is supported by NAGA’s largest shareholders.

In a combination of direct cash injections and the contribution of 100% of Capex.com shares to NAGA, the new investor will become the majority shareholder in the combined entity, which will retain the brand name NAGA. Octavian Patrascu, an experienced and prominent entrepreneur with an impressive track record in the Fintech and neo-brokerage industry, is set to become the new group CEO following this cash injection.

Octavian Patrascu, the incoming Group CEO of the combined entities, commented, "I am truly excited about this union as in today's market, consolidation can help accelerate our roadmap, objectives and give us the dimension needed for true innovation. NAGA and Capex.com have a multitude of synergies and that is why I am confidently investing my own money in this transaction. I believe we can reach our targets and am ready to embrace this new challenge to set a new benchmark in the industry."

Michael Milonas, the CEO of NAGA, added, "I am particularly pleased with this development as it unlocks value under the leadership of Octavian and becomes the cornerstone of NAGAs future success, based on three pillars. In terms of cost and revenue synergies, which will lead to a positive EBITA impact immediately. In terms of strategic synergies, the combined entity will have a much bigger footprint regarding users, licenses, and technology, which will lead to scaling the business in the medium term as well as the long term. And lastly, joint leadership is convinced about a strong cultural integration. This is the foundation of a perfect match, and I am excited about what the future holds for NAGA.”

New financial projections and research coverage for the joint group will be published in due course. The merger is expected to be completed in Q2 2024 and is subject to regulatory approvals and customary closing conditions, primarily regulatory change of control which is envisioned within a time frame of 3 to 6 months. The parties are committed to pursue an uplisting to NASDAQ as reported to the market in late 2021, which has been halted due to unfavorable market conditions. Potential interest by underwriters is to be assessed in the months following closing.

Language

English

Company

The NAGA Group AG
Hohe Bleichen 12
20354 Hamburg
Germany

E-mail

info@naga.com

Internet

www.naga.com

ISIN

DE000A161NR7

WKN

A161NR

Indices

Scale 30

Listed

Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Munich, Stuttgart, Tradegate Exchange

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Andreas Luecke
The NAGA Group AG
press@naga.com
www.naga.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF to Release First Quarter 2026 Results on May 5, 202614.4.2026 22:15:00 CEST | Press Release

IFF (NYSE: IFF) today announced that it will release its first quarter 2026 earnings results following the market close on Tuesday, May 5, 2026. The management team will host a live webcast on Wednesday, May 6, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. View source version on businesswire.com: https://www.business

AACR 2026: First‑in‑Human STC‑1010 Data Show Favorable Safety and Early Immune Engagement in Metastatic MSS Colorectal Cancer14.4.2026 20:00:00 CEST | Press Release

Brenus Pharma announced that new first‑in‑human data will be presented at the AACR Annual Meeting 2026 (April 17–22, San Diego, California). The company continues to advance its lead candidate, STC-1010, a next generation in vivo allogeneic immunotherapy built on the Stimulated Ghost Cells (SGC) technology. The poster will provide a translational overview demonstrating how STC-1010 is administrated in microsatellite‑stable colorectal cancer (MSS CRC), a setting resistant to standards immunotherapy. Clinical findings from BreAK CRC001 (NCT06934538), Phase I/IIa first‑in‑human evaluation of STC‑1010 in unresectable metastatic MSS CRC, first-line setting (n=6; median follow‑up: 6 months) show : Favorable safety with no dose‑limiting toxicities (DLTs) observed. Promising early efficacy, including 100% disease control rate (DCR) in RECIST. Evidence of immune activation, including delayed‑type hypersensitivity (DTH) responses. Exploratory analyses are ongoing to further characterize tumor–im

AACR 2026: First‑in‑Human STC‑1010 Data Show Favorable Safety and Early Immune Engagement in Metastatic MSS Colorectal Cancer14.4.2026 20:00:00 CEST | Press Release

Brenus Pharma announced that new first‑in‑human data will be presented at the AACR Annual Meeting 2026 (April 17–22, San Diego, California). The company continues to advance its lead candidate, STC-1010, a next generation in vivo allogeneic immunotherapy built on the Stimulated Ghost Cells (SGC) technology. The poster will provide a translational overview demonstrating how STC-1010 is administrated in microsatellite‑stable colorectal cancer (MSS CRC), a setting resistant to standards immunotherapy. Clinical findings from BreAK CRC001 (NCT06934538), Phase I/IIa first‑in‑human evaluation of STC‑1010 in unresectable metastatic MSS CRC, first-line setting (n=6; median follow‑up: 6 months) show : Favorable safety with no dose‑limiting toxicities (DLTs) observed. Promising early efficacy, including 100% disease control rate (DCR) in RECIST. Evidence of immune activation, including delayed‑type hypersensitivity (DTH) responses. Exploratory analyses are ongoing to further characterize tumor–im

The 2026 Japan Prize Award Ceremony Is Held With Their Majesties the Emperor and Empress of Japan in Attendance14.4.2026 19:00:00 CEST | Press Release

The Japan Prize Foundation (President: Ryozo Nagai) held an award ceremony on Tuesday, April 14, at the New National Theatre, Tokyo in Tokyo's Shibuya Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the global scientific and technological fields and who have contributed significantly to realizing peace and prosperity for all humanity. Cynthia Dwork, Ph.D. (USA), the winner in the field of Electronics, Information, and Communication, and Shizuo Akira, Ph.D. (Japan) and Zhijian “James” Chen, Ph.D. (USA), the winners in the field of Life Science, were in attendance at the award ceremony, and each field was awarded 100 million Yen together with a certificate and a medal. The winners of the 2026 Japan Prize were recommended by approximately 16,000 prominent scientists and engineers from around the world and decided by a rigorous examination taking about 1 year. The Foundation received 107 nominations for the field of Electronics, Information,

The 2026 Japan Prize Award Ceremony Is Held With Their Majesties the Emperor and Empress of Japan in Attendance14.4.2026 19:00:00 CEST | Press Release

The Japan Prize Foundation (President: Ryozo Nagai) held an award ceremony on Tuesday, April 14, at the New National Theatre, Tokyo in Tokyo's Shibuya Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the global scientific and technological fields and who have contributed significantly to realizing peace and prosperity for all humanity. Cynthia Dwork, Ph.D. (USA), the winner in the field of Electronics, Information, and Communication, and Shizuo Akira, Ph.D. (Japan) and Zhijian “James” Chen, Ph.D. (USA), the winners in the field of Life Science, were in attendance at the award ceremony, and each field was awarded 100 million Yen together with a certificate and a medal. The winners of the 2026 Japan Prize were recommended by approximately 16,000 prominent scientists and engineers from around the world and decided by a rigorous examination taking about 1 year. The Foundation received 107 nominations for the field of Electronics, Information,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye